insufficiency

(redirected from hepatic insufficiency)
Also found in: Dictionary, Medical, Legal.
Related to hepatic insufficiency: renal insufficiency, liver insufficiency
  • noun

Synonyms for insufficiency

Synonyms for insufficiency

Synonyms for insufficiency

a lack of competence

Synonyms

Related Words

(pathology) inability of a bodily part or organ to function normally

References in periodicals archive ?
It is recommended that no dose adjustment of NOXAFIL is needed in patients with mild to severe hepatic insufficiency (Child-Pugh Class A, B, and C) (See WARNINGS and DOSAGE AND ADMINISTRATION).
In patients with moderate hepatic insufficiency (Child-Pugh score 7 to 9), mean AUC and Cmax of sitagliptin increased approximately 21% and 13%, respectively, compared to healthy matched controls following administration of a single 100 mg dose of JANUVIA.
Inspra is contraindicated for use in patients with hyperkalemia (high serum potassium) at the time of initiation; in patients with moderate to severe renal insufficiency; and in patients with severe hepatic insufficiency.
The liver metabolizes almost 100% of diclofenac and there is insufficient information to support dosing recommendations in patients with hepatic insufficiency.
5 mg) and ketorolac (30 mg) were adjusted for patients with low or high body weight, and mild renal or hepatic insufficiency.
Patients with hepatic and renal impairment: Gemcitabine should be used with caution in patients with hepatic insufficiency or with impaired renal function.
Inclusion criteria allowed patients with diabetes, renal or hepatic insufficiency, and HIV/AIDS to be enrolled.
Central Daylight Time, Hall D Poster Session 82: New Drug Pharmacokinetics -- Poster A-797: Evaluation of the Safety and Pharmacokinetics of Cethromycin Following Administration of Multiple Doses to Subjects with Severe Renal Impairment -- Poster A-796: Evaluation of the Safety and Pharmacokinetics of Cethromycin Following Administration of Single and Multiple Doses to Subjects with Mild or Moderate Chronic Hepatic Insufficiency About ICAAC
APTIVUS/ritonavir is contraindicated in patients with moderate to severe (Child-Pugh Class B and C) hepatic insufficiency.
Due to the unknown effects of increased exposure to ezetimibe in patients with moderate or severe hepatic insufficiency, ezetimibe/simvastatin is not recommended in these patients.
Following administration of a single 125-mg dose of EMEND on Day 1 and 80 mg once daily on Days 2 and 3 to patients with mild hepatic insufficiency (Child-Pugh score 5 to 6), the AUC0-24hr of aprepitant was 11% lower on Day 1 and 36% lower on Day 3, as compared with healthy subjects given the same regimen.
Due to the unknown effects of increased exposure to ezetimibe (an ingredient in VYTORIN) in patients with moderate or severe hepatic insufficiency, VYTORIN is not recommended in these patients.
Elderly, debilitated, or malnourished patients, or patients with adrenal, pituitary, renal, or hepatic insufficiency may be more sensitive to the glucose-lowering effect of sulfonylureas and should be started on Avandaryl 4 mg/1 mg.
Hepatic Insufficiency Plasma concentrations of caspofungin after a single 70-mg dose in patients with mild hepatic insufficiency (Child-Pugh score 5 to 6) were increased by approximately 55% in AUC compared to healthy control subjects.
Hepatic Insufficiency In patients with moderate hepatic insufficiency (Child-Pugh score 7 to 9), mean AUC and Cmax of sitagliptin increased approximately 21% and 13%, respectively, compared to healthy matched controls following administration of a single 100 mg dose of JANUVIA.